Replies to post #601103 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

Thanks Jerry, but I'll choose to believe the nobel prize winning economist on this front!

Speculative expert testimony of Nobel prize-winning economist Prof. Paul Milgrom cited in $NWBO's 1st Amended Complaint, #1:22-cv-10185:

1. Each spoofing incident can have a permanent price impact

2. The impact is cumulative for the 2,849 spoofing incidents$AMC $GME @Citadel pic.twitter.com/niI8n7Owq7

— hoffmann6383 (@hoffmann6383) April 12, 2023

[JimSmith111]

This post relies on the $2 valuation as an arbitrary marker.

There is no explanation why a spoofing analysis should focus on the $2 marker.

A spoofing analysis does not need to focus on the $2 marker.

Your spoofing analysis focuses on the $2 marker without explanation and is entirely conclusory.